Please assess the completion status of the following clinical trial:

Trial Title: A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects with a history of SAR symptoms~* A positive skin prick test at least one grass allergen~* Moderate - severe SAR symptoms at baseline~* Women of childbearing potential must use a medically acceptable form of contraception~* 80% compliance on run in study medication and 80% compliance on completing the diary~Exclusion Criteria:~* The presence of any clinically significant comorbid disease which may interfere with the study assessments~* The presence of renal disease~* Pregnant or breastfeeding~* Subject is currently participating in another clinical trial~* Known hypersensitivity to piperazines or any of the excipients~* Intake of medications prohibited before the start of the trial~* Subjects who started or changed the dose of immunotherapy~* Rhinitis medicamentosa~* Subjects with a recent history (within the last 2 years) of drug or alcohol abuse

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Matched placebo tablets
- LCTZ (Type: EXPERIMENTAL): 5 mg tablet

Based on this trial design, predict the completion outcome and termination type (if applicable).